Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ TFPI Polyclonal Antibody

Goat Polyclonal Antibody
Supplier: Invitrogen™ PA547428
Description
In direct ELISAs and Western blots, approximately 20% cross-reactivity with recombinant human TFPI and less than 5% cross-reactivity with recombinant mouse TFPI-2 is observed. Reconstitute at 0.2 mg/mL in sterile PBS.
Tissue factor pathway inhibitor (TFPI), also known as lipoprotein-associated coagulation inhibitor, is a protease inhibitor that regulates the tissue factor (TF)-dependent pathway of blood coagulation. TFPI is glycosylated and predominantly found in the vascular endothelium and plasma in both free forms and complexed with plasma lipoproteins. The coagulation process initiates with the formation of a factor VIIa-TF complex, which proteolytically activates additional proteases (factors IX and X) and ultimately leads to the formation of a fibrin clot. TFPI inhibits the activated factor X and VIIa-TF proteases in an autoregulatory loop.
Specifications
TFPI | |
Polyclonal | |
Unconjugated | |
TFPI | |
A630013F22Rik; anti-convertin; AW552122; EPI; Extrinsic pathway inhibitor; LACI; Lipoprotein-associated coagulation inhibitor; OTTHUMP00000163472; OTTHUMP00000205431; TFI; TFPI; TFPI1; Tissue factor pathway inhibitor; tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | |
Goat | |
Antigen affinity chromatography | |
RUO | |
21788 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Lyophilized |
Immunoprecipitation, Western Blot | |
0.2 mg/mL | |
PBS with 5% trehalose and No Preservative | |
O54819 | |
TFPI | |
Mouse myeloma cell line NS0-derived recombinant mouse TFPI Leu29-Lys289. | |
100 μg | |
Primary | |
Mouse | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction